CSIMarket



Bristol myers Squibb Company  (BMY)
Other Ticker:  
 
 

BMY's Net Cash Flow Growth by Quarter and Year

Bristol Myers Squibb's Net Cash Flow results by quarter and year




BMY Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 437.00 -4,887.00 -17,669.00
III Quarter September - 2,482.00 -502.00 2,085.00
II Quarter June - 76.00 4,116.00 21,069.00
I Quarter March -1,737.00 -3,652.00 3,426.00 424.00
FY   -1,737.00 -657.00 2,153.00 5,909.00



BMY Net Cash Flow first quarter 2022 Y/Y Growth Comment
Bristol myers Squibb Company in the first quarter 2022 recorded net cash outflow of $ -1,737.00 millions.

According to the results reported in the first quarter 2022, Bristol Myers Squibb Company achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Bristol Myers Squibb Company' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter 2022.




BMY Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - 409.78 %
II Quarter June - -98.15 % -80.46 % -
I Quarter March - - 708.02 % -
FY   - - -63.56 % 296.58 %

Financial Statements
Bristol Myers Squibb's first quarter 2022 Net Cash Flow $ -1,737.00 millions BMY's Income Statement
Bristol Myers Squibb's first quarter 2021 Net Cash Flow $ -3,652.00 millions Quarterly BMY's Income Statement
New: More BMY's historic Net Cash Flow Growth >>


BMY Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -82.39 % - -
III Quarter September - 3165.79 % - -90.1 %
II Quarter June - - 20.14 % 4869.1 %
I Quarter March - - - -71.79 %
FY (Year on Year)   - - -63.56 % 296.58 %




Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Bristol Myers Squibb's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BMY's I. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -1,737.00 millions by Bristol myers Squibb Company come out even worse compare to the net cash outflow 437.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry Bristol myers Squibb Company achieved highest sequential Net Cash Flow growth. While Bristol Myers Squibb's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BMY's I. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -1,737.00 millions by Bristol myers Squibb Company look even worse considering the net cash outflow 437.00 millions a quarter before.

Within Major Pharmaceutical Preparations industry Bristol myers Squibb Company achieved highest sequential Net Cash Flow growth. While Bristol Myers Squibb's Net Cash Flow growth quarter on quarter, overall rank is .


Bristol Myers Squibb's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Cash Flow 12 Months Ending $ 1,258.00 $ -657.00 $ -5,981.00 $ -8,965.00 $ -4,925.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Bristol Myers Squibb had cumulative twelve months Net Cash Flow of $ 1,258 millions compare to net cash outflow of $ -4,925 millions a year ago.

Bristol myers Squibb Company achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1074.36 %
100.75 %
-76.44 %
(Jun 30 2019)  

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3188.92 %
581.02 %
-72.38 %
(March 31, 2009)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Bristol Myers Squibb had cumulative twelve months Net Cash Flow of $ 1,258 millions compare to net cash outflow of $ -4,925 millions a year ago.

Bristol myers Squibb Company achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1074.36 %
100.75 %
-76.44 %
(Jun 30 2019)  


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3188.92 %
581.02 %
-72.38 %
(March 31, 2009)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BMY's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BMY's Competitors
Net Cash Flow Growth for Bristol Myers Squibb's Suppliers
Net Cash Flow Growth for BMY's Customers

You may also want to know
BMY's Annual Growth Rates BMY's Profitability Ratios BMY's Asset Turnover Ratio BMY's Dividend Growth
BMY's Roe BMY's Valuation Ratios BMY's Financial Strength Ratios BMY's Dividend Payout Ratio
BMY's Roa BMY's Inventory Turnover Ratio BMY's Growth Rates BMY's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2022
Aikido Pharma Inc.-3.59%$ -3.589 millions
Quidel Corporation-3.73%$ -3.732 millions
Lineage Cell Therapeutics Inc.-5.12%$ -5.116 millions
Cv Sciences Inc.-6.75%$ -6.748 millions
Tandem Diabetes Care Inc -14.05%$ -14.050 millions
Eventbrite Inc -14.36%$ -14.358 millions
Acer Therapeutics Inc.-20.21%$ -20.211 millions
Abcellera Biologics Inc -23.09%$ -23.087 millions
China Health Industries Holdings Inc -23.82%$ -23.817 millions
Cardiovascular Systems Inc -29.81%$ -29.806 millions
Aclaris Therapeutics Inc -31.89%$ -31.892 millions
Prophase Labs Inc -33.82%$ -33.816 millions
Assertio Holdings inc -38.93%$ -38.930 millions
Co diagnostics Inc.-40.49%$ -40.492 millions
International Stem Cell Corporation-46.96%$ -46.963 millions
Intra cellular Therapies Inc -47.19%$ -47.193 millions
Phibro Animal Health Corp-49.46%$ -49.461 millions
Landos Biopharma Inc -51.20%$ -51.202 millions
Plus Therapeutics Inc -53.47%$ -53.467 millions
Clearside Biomedical Inc -55.58%$ -55.576 millions
Geovax Labs Inc -55.89%$ -55.891 millions
Diversified Healthcare Trust-55.98%$ -55.979 millions
Vaccinex Inc.-56.29%$ -56.292 millions
Ridgefield Acquisition Corp-56.53%$ -56.530 millions
Conmed Corporation-57.32%$ -57.325 millions
Celsion Corporation-57.39%$ -57.389 millions
Innoviva Inc -58.03%$ -58.034 millions
Apollo Medical Holdings Inc -59.31%$ -59.306 millions
Dariohealth Corp -62.48%$ -62.484 millions
Relmada Therapeutics Inc -62.49%$ -62.485 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CSTE's Profile

Stock Price

CSTE's Financials

Business Description

Fundamentals

Charts & Quotes

CSTE's News

Suppliers

CSTE's Competitors

Customers & Markets

Economic Indicators

CSTE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071